Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

PGK deficiency.

Ernest Beutler1

  • 1Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, CA 92037, USA. beutler@scripps.edu

British Journal of Haematology
|January 16, 2007
PubMed
Summary
This summary is machine-generated.

Phosphoglycerate kinase (PGK) deficiency, an X-linked genetic disorder, causes non-spherocytic hemolytic anemia. Mutations in the PGK1 gene lead to varied clinical symptoms, including anemia, myopathy, and neurological issues, with the cause of this variability remaining unclear.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

In Memoriam Professor Shiro Miwa.

International journal of hematology·2018
Same author

Suppression of the hepcidin-encoding gene Hamp permits iron overload in mice lacking both hemojuvelin and matriptase-2/TMPRSS6.

British journal of haematology·2009
Same author

Genetic screening for low-penetrance variants in protein-coding genes.

Annual review of genomics and human genetics·2009
Same author

Regulation of hepcidin and iron-overload disease.

Annual review of pathology·2009
Same author

The global prevalence of glucose-6-phosphate dehydrogenase deficiency: a systematic review and meta-analysis.

Blood cells, molecules & diseases·2009
Same author

Two BMP responsive elements, STAT, and bZIP/HNF4/COUP motifs of the hepcidin promoter are critical for BMP, SMAD1, and HJV responsiveness.

Blood·2008
Same journal

Author response to Zhang and Chen.

British journal of haematology·2026
Same journal

Response-adapted chimeric antigen receptor T cell (CAR-T)-sparing consolidation radiotherapy in high-risk large B-cell lymphoma (LBCL): Results of the prospective RESTART protocol.

British journal of haematology·2026
Same journal

Prospective, multicentre phase II study to evaluate the clinical benefit of reduced-dose lenalidomide and dexamethasone based on frailty stratification in elderly, unfit patients with newly diagnosed multiple myeloma.

British journal of haematology·2026
Same journal

Real-world effectiveness and safety of acalabrutinib in chronic lymphocytic leukaemia: Multicentre experience.

British journal of haematology·2026
Same journal

Novel germline GATA1s-generating variant associates with somatic STAG2 variants in hypoplastic myelodysplastic neoplasm.

British journal of haematology·2026
Same journal

The Endothelial Activation and Stress Index (EASIX) at diagnosis is associated with survival in primary central nervous system lymphoma.

British journal of haematology·2026
See all related articles

Area of Science:

  • Genetics
  • Hematology
  • Biochemistry

Background:

  • Phosphoglycerate kinase (PGK) deficiency is a rare cause of hereditary non-spherocytic hemolytic anemia (HNSHA).
  • The condition is caused by mutations in the PGK1 gene, which is X-linked.
  • Clinical manifestations are diverse, ranging from chronic hemolysis to myopathies and neurological deficits.

Purpose of the Study:

  • To review the known mutations in the PGK1 gene.
  • To explore the correlation between genotype and phenotype in PGK deficiency.
  • To understand the reasons behind the varied clinical presentations.

Main Methods:

  • Literature review of described families with PGK deficiency.
  • Analysis of genetic mutations reported in the PGK1 gene.

Related Experiment Videos

  • Correlation of mutation data with reported clinical manifestations.

    • Main Results:

    • Twenty-six families with PGK deficiency have been described.
    • Mutations have been identified in 20 of these families.
    • The specific mutations identified do not fully explain the range of clinical outcomes.

    Conclusions:

    • PGK deficiency presents with a spectrum of clinical features due to PGK1 gene mutations.
    • The underlying mechanisms causing the diverse clinical manifestations remain to be elucidated.
    • Further research is needed to understand genotype-phenotype correlations in PGK deficiency.